Aswe, Elizer R.

HRN: 14-53-45  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2024
CEFTRIAXONE 1G (VIAL)
08/20/2024
08/26/2024
IVTT
2GMS
OD
Cholangitis
Waiting Final Action 
08/20/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/20/2024
08/26/2024
IV
500mg
Q8h
Cholangitis
Waiting Final Action 
08/23/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/23/2024
08/26/2024
IV
500mg
Q6H
Hepatic Abscess
Waiting Final Action 
08/27/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/27/2024
09/03/2024
IV
4.5gms
Q6
Hepatic Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: